SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-055164
Filing Date
2021-04-27
Accepted
2021-04-27 07:35:52
Documents
16
Period of Report
2021-04-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2114105d2_8k.htm   iXBRL 8-K 31599
2 EXHIBIT 5.1 tm2114105d2_ex5-1.htm EX-5.1 10531
3 EXHIBIT 10.1 tm2114105d2_ex10-1.htm EX-10.1 195674
7 GRAPHIC tm2114105d2_ex5-1img002.jpg GRAPHIC 4801
8 GRAPHIC tm2114105d2_ex5-1img003.jpg GRAPHIC 4801
  Complete submission text file 0001104659-21-055164.txt   477063

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ocgn-20210423.xsd EX-101.SCH 3196
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocgn-20210423_lab.xml EX-101.LAB 34592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocgn-20210423_pre.xml EX-101.PRE 22717
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2114105d2_8k_htm.xml XML 3485
Mailing Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355
Business Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355 484-328-4698
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 21855884
SIC: 2836 Biological Products, (No Diagnostic Substances)